Reports
Sale
Acne Therapeutics Market Size, Share, Analysis, Forecast: By Injury Type: Complete Acne Therapeutics, Incomplete Acne Therapeutics; By Treatment Type: Therapeutics, Other Treatments; By Route of Administration: Oral, Topical, Others; By End User: Hospitals, Clinics, Others; Regional Analysis; Market Dynamics; Supplier Landscape; 2024-2032
Acne Therapeutics Market Outlook
The acne therapeutics market size was valued at USD 7.7 billion in 2023, driven by the rising emphasis on improving facial aesthetics across the major markets. The market is expected to grow at a CAGR of 4.6% during the forecast period of 2024-2032, with the values likely to rise from USD 8.1 billion in 2024 to USD 11.6 billion by 2032.
Acne Therapeutics Market Overview
The prevalence of acne is around 80% in adolescents, however, adult acne is also on the rise, projected to affect nearly 40% of the global population. Around 20% of the acne patients experience moderate to severe acne. While it is not a life-threatening condition, acne comes with psychosocial baggage and may lead to psychological issues such as anxiety, low self-esteem, and even depression. Consequently, the emergence of new treatments with the integration of the latest technologies has become one of the major acne therapeutics market trends in recent years.
Acne therapeutics include topicals and drugs such as hormonal agents or antibiotics. The alternatives vary, based on age, type, and severity of the acne. Therapies like light therapy and chemical peels are also used in some conditions. The acne therapeutics market growth is driven by expediated drug development leading to subsequent growth in FDA approvals. There is an increased focus on offering better therapeutic solutions by merging the latest gene-based therapies with combination therapies.
Increasing Integration of Artificial Intelligence Based Therapeutics
To meet the rising acne therapeutics market demand, there has been growing application of latest technologies such as artificial intelligence to develop dermatology drugs. In November 2023, a biopharmaceutical company, Almirall, with dermatology as a major domain and Absci Corporation, a generative artificial intelligence drug creation company collaborated to offer customized medicines by incorporating AI.
Rising Emphasis on Combating Antibiotic Resistance
Antibiotics for acne treatment have also been a major area of interest amongst researchers. However, broad spectrum antibiotics target both good as well as bad bacteria and antibiotic resistance, which is another key constraint that has emerged in recent years. Therefore, there is ongoing research for effective alternatives leading to substantial growth in the acne therapeutics market share.
A new Yale study, published in March 2023, examined the role of third generation of tetracycline derivative Sarecycline which directly targets Cutibacterium acnes and other gram-positive bacteria, mostly responsible for causing acne. This derivative has gained high prevalence owing to its structural competence over others, which limits the chances of mutation, therefore, opposing antibiotic resistance.
Growth in the Incidence of FDA Approvals to be a Key Driver for Market Demand
The acne therapeutics market growth is driven by increasing drug development activity and marketing authorizations by regulatory bodies. In October 2023, the FDA approved Cabtreo (clindamycin 1.2%/adapalene 0.15%/benzoyl peroxide 3.1%), which is a triple-combination topical treatment for acne. Developed by Bausch Health Companies Inc. and their dermatology business Ortho Dermatologics, this treatment combines the action mechanism of an antibiotic, retinoid and antibacterials. Isotretinoin is another high-dose vitamin A medication that shrinks sebaceous glands along with getting rid of breakout causing bacteria.
In April 2023, Dermata Therapeutics also received a positive response for initiating phase III studies for evaluating their latest once-a-week topical acne treatment DMT310. Derived from naturally sourced freshwater sponge, this drug is also being studied to treat rosacea and psoriasis. To expand their product line, the company is working towards developing a new candidate DMT410, that will employ a needle free intradermal administration of botulinum toxin to treat various aesthetic and medical skin conditions. Consequently, the acne therapeutics market size is expected to grow with ongoing advancements in the pharmaceutical domain.
Acne Therapeutics Market Segmentation
Market Breakup by Injury Type
- Complete Acne Therapeutics
- Incomplete Acne Therapeutics
Market Breakup by Treatment Type
- Therapeutics
- Retinoid
- Antibiotics
- Hormonal Agents
- Anti-inflammatory
- Other Agents
- Other Treatments
Market Breakup by Route of Administration
- Oral
- Topical
- Others
Market Breakup by End User
- Hospitals
- Clinics
- Others
Market Breakup by Region
- United States
- EU-4 and the United Kingdom
- Germany
- France
- Italy
- Spain
- Japan
Acne Therapeutics Market Overview
Acne is the most common skin condition in the United States, affecting approximately 3 million people every year. So, the United States is anticipated to lead the acne therapeutics market share. The emphasis on product line expansion is a vital aspect of the market size. In October 2023, Crown Therapeutics unveiled two new products in their dermatologist backed award winning product line. PanOxyl Clarifying Exfoliant with 2% Salicylic Acid and PanOxyl Adapalene 0.1% Gel are clinically proven to treat acne with their high-performance ingredients.
Europe is another key player of the market with hefty investments occurring in various key conditions. In March 2023, a Swedish pharmaceutical company, Vakona, received USD 13.4 million investment from five investors to develop a new acne treatment drug. In addition, the presence of academic and research institutions is also a key aspect of growing market value.
The Asia Pacific acne therapeutics market value is expected to rise with increasing engagement of government and private sector companies to improve the healthcare infrastructure available in the region. In addition, there are several mergers and acquisitions occurring to offer better treatment alternatives to patients, which is fueling the market growth in the region.
Acne Therapeutics Market: Competitor Landscape
In December 2023, Eligo Bioscience, a gene-editing company, received a USD 30 million Series B funding by Sanofi Ventures for their flagship program EB005. This program is aimed at treating moderate to severe acne vulgaris with the application of in vivo gene-editing techniques. Such investments indicate the growing trend of using novel technologies to address diseases triggered by expression of bacterial genes.
The key features of the acne therapeutics market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Cipher Pharmaceuticals
- GlaxoSmithKline PLC
- L'Oréal S.A. (La Roche-Posay Laboratoire Dermatologique)
- Teva Pharmaceuticals
- Sun Pharmaceuticals
- Abbvie Inc.
- F. Hoffmann-la Roche Ltd
- Viatris Inc.
- Johnson & Johnson
- Bausch Health Companies Inc.
- Perricone MD
- Glow Biotics LLC
- Revision Skincare
- The Beauty Health Company
- PHYTOMER
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Injury Type |
|
| Breakup by Treatment Type |
|
| Breakup by Route of Administration |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Acne Overview
3.1 Guidelines and Stages
3.2 Pathophysiology
3.3 Screening and Diagnosis
3.4 Treatment Pathway
4 Patient Profile
4.1 Patient Profile Overview
4.2 Patient Psychology and Emotional Impact Factors
4.3 Risk Assessment and Treatment Success Rate
5 Acne Epidemiology Analysis – Seven Major Markets
5.1 7MM Epidemiology Scenario Overview (2017-2032)
5.2 United States Acne Epidemiology Forecast (2017-2032)
5.3 EU-4 and United Kingdom Acne Epidemiology Forecast (2017-2032)
5.3.1 Germany Acne Epidemiology Forecast (2017-2032)
5.3.2 France Acne Epidemiology Forecast (2017-2032)
5.3.3 Italy Acne Epidemiology Forecast (2017-2032)
5.3.4 Spain Acne Epidemiology Forecast (2017-2032)
5.3.5 United Kingdom Acne Epidemiology Forecast (2017-2032)
5.4 Japan Acne Epidemiology Forecast (2017-2032)
6 Acne Therapeutics Market Overview – 7MM
6.1 Acne Therapeutics Market Historical Value (2017-2023)
6.2 Acne Therapeutics Market Forecast Value (2024-2032)
7 Acne Therapeutics Market Landscape – 7MM
7.1 Acne Therapeutics: Developers Landscape
7.1.1 Analysis by Year of Establishment
7.1.2 Analysis by Company Size
7.1.3 Analysis by Region
7.2 Acne Therapeutics: Product Landscape
7.2.1 Analysis by Injury Type
7.2.2 Analysis by Route of Administration
8 Acne Therapeutics Challenges and Unmet Needs
8.1 Treatment Pathway Challenges
8.2 Compliance and Drop-Out Analysis
8.3 Awareness and Prevention Gaps
9 Cost of Treatment
10 Acne Therapeutics Market Dynamics
10.1 Market Drivers and Constraints
10.2 SWOT Analysis
10.3 Porter’s Five Forces Model
10.4 Key Demand Indicators
10.5 Key Price Indicators
10.6 Industry Events, Initiatives, and Trends
10.7 Value Chain Analysis
11 Acne Therapeutics Market Segmentation – Seven Major Markets
11.1 Acne Therapeutics Market by Injury Type
11.1.1 Market Overview
11.1.2 Complete Acne Therapeutics
11.1.3 Incomplete Acne Therapeutics
11.2 Acne Therapeutics Market by Treatment Type
11.2.1 Market Overview
11.2.2 Therapeutics
11.2.2.1 Retinoid
11.2.2.2 Antibiotics
11.2.2.3 Hormonal Agents
11.2.2.4 Anti-inflammatory
11.2.2.5 Other Agents
11.2.3 Other Treatments
11.3 Acne Therapeutics Market by Route of Administration
11.3.1 Market Overview
11.3.2 Oral
11.3.3 Topical
11.3.4 Others
11.4 Acne Therapeutics Market by End User
11.4.1 Market Overview
11.4.2 Hospitals
11.4.3 Clinics
11.4.4 Others
11.5 Acne Therapeutics Market by Region
11.5.1 Market Overview
11.5.2 United States
11.5.3 EU-4 and the United Kingdom
11.5.3.1 Germany
11.5.3.2 France
11.5.3.3 Italy
11.5.3.4 Spain
11.5.3.5 United Kingdom
11.6 Japan
12 United States Acne Therapeutics Market
12.1 Acne Therapeutics Market Historical Value (2017-2023)
12.2 Acne Therapeutics Market Forecast Value (2024-2032)
12.2.1 Acne Therapeutics Market by Injury Type
12.2.2 Acne Therapeutics Market by Treatment Type
13 EU-4 and United Kingdom Acne Therapeutics Market
13.1 Acne Therapeutics Market Historical Value (2017-2023)
13.2 Acne Therapeutics Market Forecast Value (2024-2032)
13.3 Germany Acne Therapeutics Market Overview
13.3.1 Acne Therapeutics Market by Injury Type
13.3.2 Acne Therapeutics Market by Treatment Type
13.4 France Acne Therapeutics Market Overview
13.4.1 Acne Therapeutics Market by Injury Type
13.4.2 Acne Therapeutics Market by Treatment Type
13.5 Italy Acne Therapeutics Market Overview
13.5.1 Acne Therapeutics Market by Injury Type
13.5.2 Acne Therapeutics Market by Treatment Type
13.6 Spain Acne Therapeutics Market Overview
13.6.1 Acne Therapeutics Market by Injury Type
13.6.2 Acne Therapeutics Market by Treatment Type
13.7 United Kingdom Acne Therapeutics Market Overview
13.7.1 Acne Therapeutics Market by Injury Type
13.7.2 Acne Therapeutics Market by Treatment Type
14 Japan Acne Therapeutics Market
14.1 Acne Therapeutics Market Historical Value (2017-2023)
14.2 Acne Therapeutics Market Forecast Value (2024-2032)
14.1.1 Acne Therapeutics Market by Injury Type
14.1.2 Acne Therapeutics Market by Treatment Type
15 Regulatory Framework
15.1 Regulatory Overview
15.1.1 US FDA
15.1.2 EU EMA
15.1.3 INDIA CDSCO
15.1.4 JAPAN PMDA
15.1.5 Others
16 Patent Analysis
16.1 Analysis by Type of Patent
16.2 Analysis by Publication year
16.3 Analysis by Issuing Authority
16.4 Analysis by Patent Age
16.5 Analysis by CPC Analysis
16.6 Analysis by Patent Valuation
16.7 Analysis by Key Players
17 Grants Analysis
17.1 Analysis by year
17.2 Analysis by Amount Awarded
17.3 Analysis by Issuing Authority
17.4 Analysis by Grant Application
17.5 Analysis by Funding Institute
17.6 Analysis by NIH Departments
17.7 Analysis by Recipient Organization
18 Clinical Trials Analysis
18.1 Analysis by Trial Registration Year
18.2 Analysis by Trial Status
18.3 Analysis by Trial Phase
18.4 Analysis by Therapeutic Area
18.5 Analysis by Geography
19 Funding and Investment Analysis
19.1 Analysis by Funding Instances
19.2 Analysis by Type of Funding
19.3 Analysis by Funding Amount
19.4 Analysis by Leading Players
19.5 Analysis by Leading Investors
19.6 Analysis by Geography
20 Partnership and Collaborations Analysis
20.1 Analysis by Partnership Instances
20.2 Analysis by Type of Partnership
20.3 Analysis by Leading Players
20.4 Analysis by Geography
21 Supplier Landscape
21.1 Cipher Pharmaceuticals
21.1.1 Financial Analysis
21.1.2 Product Portfolio
21.1.3 Demographic Reach and Achievements
21.1.4 Mergers and Acquisitions
21.1.5 Certifications
21.2 GlaxoSmithKline PLC
21.2.1 Financial Analysis
21.2.2 Product Portfolio
21.2.3 Demographic Reach and Achievements
21.2.4 Mergers and Acquisitions
21.2.5 Certifications
21.3 L'Oréal S.A. (La Roche-Posay Laboratoire Dermatologique)
21.3.1 Financial Analysis
21.3.2 Product Portfolio
21.3.3 Demographic Reach and Achievements
21.3.4 Mergers and Acquisitions
21.3.5 Certifications
21.4 Teva Pharmaceuticals
21.4.1 Financial Analysis
21.4.2 Product Portfolio
21.4.3 Demographic Reach and Achievements
21.4.4 Mergers and Acquisitions
21.4.5 Certifications
21.5 Sun Pharmaceuticals
21.5.1 Financial Analysis
21.5.2 Product Portfolio
21.5.3 Demographic Reach and Achievements
21.5.4 Mergers and Acquisitions
21.5.5 Certifications
21.6 Abbvie Inc.
21.6.1 Financial Analysis
21.6.2 Product Portfolio
21.6.3 Demographic Reach and Achievements
21.6.4 Mergers and Acquisitions
21.6.5 Certifications
21.7 F. Hoffmann-la Roche Ltd
21.7.1 Financial Analysis
21.7.2 Product Portfolio
21.7.3 Demographic Reach and Achievements
21.7.4 Mergers and Acquisitions
21.7.5 Certifications
21.8 Viatris Inc.
21.8.1 Financial Analysis
21.8.2 Product Portfolio
21.8.3 Demographic Reach and Achievements
21.8.4 Mergers and Acquisitions
21.8.5 Certifications
21.9 Johnson & Johnson
21.9.1 Financial Analysis
21.9.2 Product Portfolio
21.9.3 Demographic Reach and Achievements
21.9.4 Mergers and Acquisitions
21.9.5 Certifications
21.10 Bausch Health Companies Inc.
21.10.1 Financial Analysis
21.10.2 Product Portfolio
21.10.3 Demographic Reach and Achievements
21.10.4 Mergers and Acquisitions
21.10.5 Certifications
21.11 Perricone MD
21.11.1 Financial Analysis
21.11.2 Product Portfolio
21.11.3 Demographic Reach and Achievements
21.11.4 Mergers and Acquisitions
21.11.5 Certifications
21.12 Glow Biotics LLC
21.12.1 Financial Analysis
21.12.2 Product Portfolio
21.12.3 Demographic Reach and Achievements
21.12.4 Mergers and Acquisitions
21.12.5 Certifications
21.13 Revision Skincare
21.13.1 Financial Analysis
21.13.2 Product Portfolio
21.13.3 Demographic Reach and Achievements
21.13.4 Mergers and Acquisitions
21.13.5 Certifications
21.14 The Beauty Health Company
21.14.1 Financial Analysis
21.14.2 Product Portfolio
21.14.3 Demographic Reach and Achievements
21.14.4 Mergers and Acquisitions
21.14.5 Certifications
21.15 PHYTOMER
21.15.1 Financial Analysis
21.15.2 Product Portfolio
21.15.3 Demographic Reach and Achievements
21.15.4 Mergers and Acquisitions
21.15.5 Certifications
22 Acne Therapeutics - Distribution Model (Additional Insight)
22.1 Overview
22.2 Potential Distributors
22.3 Key Parameters for Distribution Partner Assessment
23 Key Opinion Leaders (KOL) Insights (Additional Insight)
24 Company Competitiveness Analysis (Additional Insight)
24.1 Very Small Companies
24.2 Small Companies
24.3 Mid-Sized Companies
24.4 Large Companies
24.5 Very Large Companies
25 Payment Methods (Additional Insight)
25.1 Government Funded
25.2 Private Insurance
25.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
The market attained a value of about USD 7.7 billion in 2023, driven by increasing emphasis on improving facial aesthetics across the globe.
The market is anticipated to grow at a CAGR of 4.6% during the forecast period of 2024-2032, likely to reach a market value of USD 11.6 billion by 2032.
The market demand is driven by the increasing incidence of acne and other dermatological issues in adolescents as well as adults. The growing research initiatives and investments by impactful pharmaceutical companies and research institutions, along with focus on offering personalised solutions to the patients, is another major factor driving the demand.
The major market trend involves the adoption of artificial intelligence to develop drugs. In November 2023, Almirall, a biopharmaceutical company in dermatology domain and Absci Corporation, a generative artificial intelligence drug creation company entered a partnership to develop acne drugs.
Based on injury types, the market is divided into complete and incomplete acne therapeutics.
The treatments in the market include therapeutics like retinoid, antibiotics, hormonal agents, anti-inflammatory, and other agents. There are some other treatments available in the market.
Major end users in the market include hospitals and clinics, among others.
The major regions of the market include the United States, Japan, EU-4, which is segmented into Germany, France, Italy, Spain, and the United Kingdom.
Key players involved in the market are Cipher Pharmaceuticals, GlaxoSmithKline PLC, L'Oréal S.A. (La Roche-Posay Laboratoire Dermatologique), Teva Pharmaceuticals, Sun Pharmaceuticals, Abbvie Inc., F. Hoffmann-la Roche Ltd., Viatris Inc., Johnson & Johnson, Bausch Health Companies Inc., Perricone MD, Glow Biotics LLC, Revision Skincare, The Beauty Health Company, and PHYTOMER.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 3299
$2999
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 6599
$5999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 8799
$7999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 9899
$8999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER